DKSH and Boehringer Ingelheim to improve access to treatment in Myanmar
23-May-17, 4-traders
Market expansion company DKSH and pharma company Boehringer Ingelheim have signed an agreement to provide Myanmar patients better treatment options.
%20DKSH.jpeg "DKSH and Boehringer Ingelheim to improve access to treatment in Myanmar (c) DKSH")
Image: DKSH
DKSH will provide marketing, sales, distribution and logistics services for Boehringer Ingelheim across pharmacies, hospitals and clinics in Myanmar. The agreement will give patients in Myanmar access to new medicine for vascular diseases, arterial hypertension, cancer and diabetes.
The collaboration is an extension of a partnership that includes Cambodia, Singapore and Thailand.